Incyte
Breakthrough Therapy for Advanced Cholangiocarcinoma Approved
The FDA granted accelerated approval to pemigatinib (Pemazyre, Incyte Corporation), the first treatment approved ...
APRIL 20, 2020
FDA Approves Jakafi to Treat Acute GVHD
The FDA granted a new indication for Jakafi to treat steroid-refractory acute graft-versus-host disease in adults ...
MAY 28, 2019
Load more